Archives - Page 2

• 

  Special Supplement, June 2022

  • Safety and tolerability of Bruton's tyrosine kinase inhibitors in the treatment of Waldenström macroglobulinemia
• 

  Volume 1, Issue 1, March 2022

  • Next-generation sequencing for myeloid malignancies: Progress and practical applications
  • Management of follicular lymphoma at first relapse
  • Myeloproliferative neoplasms in 2022: A concise review
  • Diagnosis and treatment of AL amyloidosis in 2022
  • To transplant or not to transplant in multiple myeloma
  • Emerging therapeutic agents in the treatment of relapsed or refractory diffuse large B cell lymphoma